Appendix C. List of organisations involved in this appraisal

Appendix C. List of organisations involved in this appraisal

The following organisations are consultees/commentators in this appraisal. Consultees are also invited to appeal against the Final Appraisal Determination.

I) Professional/specialist and patient/carer groups:

  • Association of Cancer Physicians

  • Association of Surgeons of Great Britain and Ireland

  • British Association of Surgical Oncology

  • British Oncological Association

  • British Oncology Pharmacy Association (BOPA)

  • British Psychosocial Oncology Society (BPOS)

  • Cancer Research UK

  • Community Practitioners' & Health Visitors' Association

  • Medical Women's Federation

  • Royal of General Practitioners

  • Royal College

  • Royal of Pathologists

  • Royal of Physicians' Medical Oncology Joint Special Committee

  • Royal of Radiologists

  • Royal of Surgeons

  • Royal Pharmaceutical Society

  • Breakthrough Breast Cancer

  • Breast Cancer Campaign

  • Breast Cancer Care

  • Cancer Voices

  • Cancerbackup

  • Long-term Medical Conditions Alliance

  • Macmillan Cancer Relief

  • Marie Curie Cancer Care

  • National Cancer Alliance

  • National Council for Palliative Care

  • Tenovus Cancer Information Centre

II) Commentator organisations (without the right of appeal):

  • Board of Community Health Councils in Wales

  • British National Formulary

  • Medicines and Healthcare products Regulatory Agency (MHRA)

  • National Public Health Service for Wales

  • NHS Confederation

  • NHS Purchasing and Supplies Agency

  • NHS Quality Improvement Scotland

  • Baxter Healthcare Ltd

  • Bayer plc

  • Bristol-Myers Squibb Pharmaceuticals Ltd

  • Genus Pharmaceuticals

  • GlaxoSmithKline

  • Goldshield Pharmaceuticals Ltd

  • Kyowa Hakko UK Ltd

  • Mayne Pharma plc

  • Medac UK

  • Pfizer Ltd [Pharmacia]

  • Pierre Fabre Ltd

  • Roche Products Ltd

  • Sanofi-Aventis

  • Schering-Plough Ltd

  • Wyeth Pharmaceuticals

  • Cochrane Collaboration – Cochrane Breast Cancer Group

  • Institute Research

  • MRC Clinical Trials Unit

  • National Cancer Research Institute

  • National Coordinating Centre for Health Technology Assessment

  • Southampton Health Technology Assessment Centre

  • National Collaborating Centre for Cancer